Transmission Pattern of Measles Virus Circulating in China During 1993-2021: Genotyping Evidence Supports That China Is Approaching Measles Elimination.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
08 02 2023
Historique:
received: 06 04 2022
pubmed: 30 8 2022
medline: 11 2 2023
entrez: 29 8 2022
Statut: ppublish

Résumé

To provide useful insights into measles elimination progress in China, measles surveillance data were reviewed, and the transmission patterns of measles viruses circulating in China during 1993-2021 were analyzed. Measles incidence data from the National Notifiable Disease Reporting System of the China Center for Disease Control and Prevention were analyzed. A total of 17 570 strains were obtained from 30 of 31 provinces in mainland China during 1993-2021. The recommended genotyping window was amplified. Genotyping analysis was conducted for comparison with the reference strains. Phylogenetic analyses were performed to identify genetic relationships among different lineages within the genotypes. With high coverage of routine immunization and intensive supplementary immunization activities, measles incidence has shown a downward trend since 1993, despite 2 resurgences, reaching a historic low level in 2020-2021 (average 0.5 per million). During 1993-2021, 9 genotypes including domestic genotype H1; imported genotypes B3, D4, D8, D9, D11, G3, and H2; and vaccine-associated genotype A were identified. Among them, the genotype H1 strain circulated endemically in China for more than 25 years; the last strain was detected in Yunnan Province in September 2019. Multiple imported genotypes have been identified since 2009 showing different transmission patterns. Since April 2020, no imported strains have been detected, while vaccine-associated genotype A continues to be detected. The evidence of low incidence during 2020-2021 and virological surveillance data in this study confirm that China is currently approaching measles elimination.

Sections du résumé

BACKGROUND
To provide useful insights into measles elimination progress in China, measles surveillance data were reviewed, and the transmission patterns of measles viruses circulating in China during 1993-2021 were analyzed.
METHODS
Measles incidence data from the National Notifiable Disease Reporting System of the China Center for Disease Control and Prevention were analyzed. A total of 17 570 strains were obtained from 30 of 31 provinces in mainland China during 1993-2021. The recommended genotyping window was amplified. Genotyping analysis was conducted for comparison with the reference strains. Phylogenetic analyses were performed to identify genetic relationships among different lineages within the genotypes.
RESULTS
With high coverage of routine immunization and intensive supplementary immunization activities, measles incidence has shown a downward trend since 1993, despite 2 resurgences, reaching a historic low level in 2020-2021 (average 0.5 per million). During 1993-2021, 9 genotypes including domestic genotype H1; imported genotypes B3, D4, D8, D9, D11, G3, and H2; and vaccine-associated genotype A were identified. Among them, the genotype H1 strain circulated endemically in China for more than 25 years; the last strain was detected in Yunnan Province in September 2019. Multiple imported genotypes have been identified since 2009 showing different transmission patterns. Since April 2020, no imported strains have been detected, while vaccine-associated genotype A continues to be detected.
CONCLUSIONS
The evidence of low incidence during 2020-2021 and virological surveillance data in this study confirm that China is currently approaching measles elimination.

Identifiants

pubmed: 36037029
pii: 6678598
doi: 10.1093/cid/ciac674
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1140-e1149

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Auteurs

Huiling Wang (H)

World Health Organization Western Pacific Regional Office Regional Reference Laboratory of Measles and Rubella, National Health Commission Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Zhen Zhu (Z)

World Health Organization Western Pacific Regional Office Regional Reference Laboratory of Measles and Rubella, National Health Commission Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Xiaojian Duan (X)

World Health Organization Western Pacific Regional Office Regional Reference Laboratory of Measles and Rubella, National Health Commission Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Jinhua Song (J)

World Health Organization Western Pacific Regional Office Regional Reference Laboratory of Measles and Rubella, National Health Commission Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Naiying Mao (N)

World Health Organization Western Pacific Regional Office Regional Reference Laboratory of Measles and Rubella, National Health Commission Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Aili Cui (A)

World Health Organization Western Pacific Regional Office Regional Reference Laboratory of Measles and Rubella, National Health Commission Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Changyin Wang (C)

Provincial Measles/Rubella Laboratory, Shandong Provincial Center for Disease Control and Prevention, Jinan, China.

Hui Du (H)

Provincial Measles/Rubella Laboratory, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, China.

Yan Wang (Y)

Provincial Measles/Rubella Laboratory, Liaoning Provincial Center for Disease Control and Prevention, Shenyang, China.

Fangcai Li (F)

Provincial Measles/Rubella Laboratory, Hunan Provincial Center for Disease Control and Prevention, Changsha, China.

Shujie Zhou (S)

Provincial Measles/Rubella Laboratory, Anhui Provincial Center for Disease Control and Prevention, Hefei, China.

Daxing Feng (D)

Provincial Measles/Rubella Laboratory, Henan Provincial Center for Disease Control and Prevention, Zhengzhou, China.

Chongshan Li (C)

Provincial Measles/Rubella Laboratory, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China.

Hui Gao (H)

Provincial Measles/Rubella Laboratory, Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, China.

Jilan He (J)

Provincial Measles/Rubella Laboratory, Sichuan Provincial Center for Disease Control and Prevention, Chengdu, China.

Liqun Li (L)

Provincial Measles/Rubella Laboratory, Yunnan Provincial Center for Disease Control and Prevention, Kunming, China.

Yue Lei (Y)

Provincial Measles/Rubella Laboratory, Tianjin Municipal Center for Disease Control and Prevention, Tianjin, China.

Huanying Zheng (H)

Provincial Measles/Rubella Laboratory, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.

Tian Gong (T)

Provincial Measles/Rubella Laboratory, Jiangxi Provincial Center for Disease Control and Prevention, Nanchang, China.

Ying Hu (Y)

Provincial Measles/Rubella Laboratory, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.

Changping Xu (C)

Provincial Measles/Rubella Laboratory, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.

Hua Zhao (H)

Provincial Measles/Rubella Laboratory, Chongqing Municipal Center for Disease Control and Prevention, Chongqing, China.

Zhaodan Sun (Z)

Provincial Measles/Rubella Laboratory, Heilongjiang Provincial Center for Disease Control and Prevention, Ha'erbin, China.

Ying Chen (Y)

Provincial Measles/Rubella Laboratory, Gansu Provincial Center for Disease Control and Prevention, Lanzhou, China.

Xiaomin Tang (X)

Provincial Measles/Rubella Laboratory, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China.

Meng Chen (M)

Provincial Measles/Rubella Laboratory, Beijing Municipal Center for Disease Control and Prevention, Beijing, China.

Lili Deng (L)

Provincial Measles/Rubella Laboratory, Guangxi Center for Disease Control and Prevention, Nanning, China.

Shuang Wang (S)

Provincial Measles/Rubella Laboratory, Jilin Provincial Center for Disease Control and Prevention, Changchun, China.

Xiaoling Tian (X)

Provincial Measles/Rubella Laboratory, Neimenggu Center for Disease Control and Prevention, Huhehaote, China.

Ting Zhang (T)

Provincial Measles/Rubella Laboratory, Hubei Provincial Center for Disease Control and Prevention, Wuhan, China.

Yuan Si (Y)

Provincial Measles/Rubella Laboratory, Shaanxi Provincial Center for Disease Control and Prevention, Xian, China.

Fang Yuan (F)

Provincial Measles/Rubella Laboratory, Ningxia Center for Disease Control and Prevention, Yinchuan, China.

Lixia Fan (L)

Provincial Measles/Rubella Laboratory, Qinghai Provincial Center for Disease Control and Prevention, Xining, China.

Kuerban Mahemutijiang (K)

Provincial Measles/Rubella Laboratory, Xinjiang Center for Disease Control and Prevention, Wulumuqi, China.

Zhifei Chen (Z)

Provincial Measles/Rubella Laboratory, Fujian Provincial Center for Disease Control and Prevention, Fuzhou, China.

Haiyun Chen (H)

Provincial Measles/Rubella Laboratory, Hainan Provincial Center for Disease Control and Prevention, Haikou, China.

Wenbo Xu (W)

World Health Organization Western Pacific Regional Office Regional Reference Laboratory of Measles and Rubella, National Health Commission Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Yan Zhang (Y)

World Health Organization Western Pacific Regional Office Regional Reference Laboratory of Measles and Rubella, National Health Commission Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH